Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Insulin-Like Growth Factor Binding Protein-3 (IGFBP3) Gene Expression In Myeloma Cell Lines and Patients

Alessandra Perego, Prerna Tewari, Mark Lawler, Paul Browne, Stephen Drain, Mark Catherwood, Giuseppe Limonta, Daniele Perego, Manuela Carrera, Enrico Maria Pogliani, MD

Blood (2010) 116 (21): 2489.

https://doi.org/10.1182/blood.V116.21.2489.2489

Published: 2010

Journal Articles

Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide

Prerna Tewari, Elaine Kenny, Anthony Staines, Stephen Chanock, Paul Browne, Mark Lawler

Blood (2009) 113 (22): 5691–5692.

https://doi.org/10.1182/blood-2009-03-211177

Published: 2009

Journal Articles

Variation in DNA Repair Genes XRCC3, XRCC4, and XRCC5 and Risk of Myeloma.

Patrick Hayden, MD, Prerna Tewari, PhD, Anthony Staines, MD, Derek Morris, PhD, Dominique Crowley, MD, Alexandra Nieters, PhD, Nicholas Becker, MD, Silvia de Sanjose, MD, L. Foretova, MD, Mark Maynardie, MD, Pier Luigi Coco, MD, Paolo Boefetta, PhD, Paul Brennan, PhD, Paul V. Browne, MD, Mark Lawler, PhD

Blood (2006) 108 (11): 3416.

https://doi.org/10.1182/blood.V108.11.3416.3416

Published: 2006

Journal Articles

The EuroChimerism Concept for a Standardized Approach to Chimerism Analysis Following Allogeneic Stem Cell Transplantation.

Thomas Lion, Marcel Tilanus, Hélène Cavé, Mark Lawler, Anna Serra, Andrea Biondi, Jacques van Dongen, Marcos González, Gisela Barbany, Eddy Roosnek, Colin Steward, Peter Bader

Blood (2006) 108 (11): 621.

https://doi.org/10.1182/blood.V108.11.621.621

Published: 2006

Journal Articles

Imatinib Mesylate Treatment of Patients with Chronic Myeloid Leukaemia Relapsing Following Allogeneic Stem Cell Transplantation.

Eibhlin Conneally, MB, Ph. D, Peig Carroll, B.Sc, Michael Neat, M.Sc, Karl Haslam, M.Sc, Kathy Gately, Ph.D, Jacqui Ryan, M.SC, Mark Lawler, Ph.D, Shaun McCann, MB

Blood (2004) 104 (11): 4659.

https://doi.org/10.1182/blood.V104.11.4659.4659

Published: 2004

Journal Articles

Favourable Impact on Acute and Chronic Graft-Versus-Host Disease with Cyclophosphamide and In-Vivo Anti-CD52 Monoclonal Antibodies for Marrow Transplantation from HLA-Identical Sibling Donors for Acquired Aplastic Anaemia.

Vikas Gupta, Sarah E. Ball, Qi-long Yi, Deborah Sage, Shaun R. McCann, Mark Lawler, Miguel Ortin, Mylene Freires, Geoff Hale, Hermann Waldmann, Edward C. Gordon-Smith, Judith C.W. Marsh

Blood (2004) 104 (11): 3333.

https://doi.org/10.1182/blood.V104.11.3333.3333

Published: 2004

Journal Articles

Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study

Lorraine Tracey, Raquel Villuendas, Ana Maria Dotor, Inmaculada Spiteri, Pablo Ortiz, Juan F. García, Jose Luis Rodríguez Peralto, Mark Lawler, Miguel A. Piris

Blood (2003) 102 (3): 1042–1050.

https://doi.org/10.1182/blood-2002-11-3574

Published: 2003

Journal Articles

Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML

Shaun R. McCann, Kathy Gately, Eibhlin Conneally, Mark Lawler

Blood (2003) 101 (3): 1200.

https://doi.org/10.1182/blood-2002-09-2932

Published: 2003

Journal Articles

Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial

Franco Locatelli, Barbara Bruno, Marco Zecca, Maria Teresa Van-Lint, Shaun McCann, William Arcese, Sandro Dallorso, Paolo Di Bartolomeo, Franca Fagioli, Anna Locasciulli, Mark Lawler, Andrea Bacigalupo

Blood (2000) 96 (5): 1690–1697.

https://doi.org/10.1182/blood.V96.5.1690

Published: 2000

Journal Articles

Chimerism Following Donor Lymphocyte Infusion for Chronic Myeloid Leukemia

Nicola Gardiner, Shaun R. McCann, Joan O’Riordan, Mark Lawler

Blood (1999) 93 (8): 2748–2749.

https://doi.org/10.1182/blood.V93.8.2748

Published: 1999

NARROW

Insulin-Like Growth Factor Binding Protein-3 (IGFBP3) Gene Expression In Myeloma Cell Lines and Patients

Genetic variants in XRRC5 may predict development of venous thrombotic events in myeloma patients on thalidomide

Variation in DNA Repair Genes XRCC3, XRCC4, and XRCC5 and Risk of Myeloma.

The EuroChimerism Concept for a Standardized Approach to Chimerism Analysis Following Allogeneic Stem Cell Transplantation.

Imatinib Mesylate Treatment of Patients with Chronic Myeloid Leukaemia Relapsing Following Allogeneic Stem Cell Transplantation.

Favourable Impact on Acute and Chronic Graft-Versus-Host Disease with Cyclophosphamide and In-Vivo Anti-CD52 Monoclonal Antibodies for Marrow Transplantation from HLA-Identical Sibling Donors for Acquired Aplastic Anaemia.

Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study

Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML

Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial

Chimerism Following Donor Lymphocyte Infusion for Chronic Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only